Related Experiment Videos
Zuclopenthixol levels in serum and breast milk
Psychopharmacology
|January 1, 1986
Summary
Zuclopenthixol in breast milk is 29% of maternal serum levels. Infant doses are very low, likely causing no adverse effects, as seen in this study.
Area of Science:
- Pharmacology
- Psychiatry
- Neonatology
Background:
- Antipsychotic use during postpartum is common.
- Concerns exist regarding medication transfer to infants via breast milk.
- Zuclopenthixol is an antipsychotic used in managing postpartum psychosis.
Purpose of the Study:
- To quantify zuclopenthixol levels in breast milk.
- To estimate the resulting dose in breastfed infants.
- To assess potential risks to nursing infants.
Main Methods:
- Collected breast milk and serum samples from six mothers using zuclopenthixol.
- Analyzed drug concentrations using high-performance liquid chromatography (HPLC).
- Calculated infant dosage based on milk levels and average consumption.
Main Results:
- Average zuclopenthixol milk levels were 29% of serum levels.
- Estimated daily infant dose ranged from 0.5-5 micrograms.
- No apparent adverse effects were observed in the studied infants.
Conclusions:
- Postpartum maternal zuclopenthixol treatment results in low infant exposure via breast milk.
- The estimated infant dose is unlikely to cause adverse effects.
- Further research may explore infant metabolism and sensitivity differences.